Holen Sie sich die Stockscreener-App
1.80
4.05%
0.07
Schlusskurs vom Vortag:
$1.73
Offen:
$1.73
24-Stunden-Volumen:
162.47K
Relative Volume:
0.50
Marktkapitalisierung:
$213.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.73M
KGV:
-13.85
EPS:
-0.13
Netto-Cashflow:
$-3.92M
1W Leistung:
+6.51%
1M Leistung:
+2.86%
6M Leistung:
+31.39%
1J Leistung:
+83.09%
1-Tages-Spanne:
$1.70
$1.80
1-Wochen-Bereich:
$1.62
$1.80
52-Wochen-Spanne:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Firmenname
Tiziana Life Sciences Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie TLSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.80 | 205.57M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2018-12-17 | Eingeleitet | Laidlaw | Buy |
Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten
Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN
Will Tiziana Life Sciences Ltd stock deliver shareholder valueInsider Buying & Daily Stock Trend Watchlist - Newser
How Tiziana Life Sciences Ltd stock reacts to job market data2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Is Tiziana Life Sciences Ltd stock near bottom after declineJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser
Will Tiziana Life Sciences Ltd stock attract ESG investorsWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Tiziana Life Sciences Ltd (TLSA) is looking forward to a strong quarter - Setenews
Is KN Agri Resources Limited Stock a Safe Long Term Investment Data Breakdown - earlytimes.in
Is Tiziana Life Sciences Ltd a good long term investmentEarnings Forecast Updates & Manage Volatility With Calm, Data-Backed Moves - earlytimes.in
Is Tiziana Life Sciences Ltd stock undervalued vs historical averagesTrade Exit Report & Weekly Stock Breakout Alerts - Newser
Small cap wrap: Tiziana Life Sciences, Gunnison Copper, Blockmate Ventures, Century Lithium… - Proactive Investors
Tiziana Life Sciences to Set Up a Publicly Listed Immunology-Focused Spinout Company, Centered on the IL-6 Market - marketscreener.com
Tiziana Life Sciences stock falls after announcing IL-6 asset spinout By Investing.com - Investing.com Nigeria
Tiziana Life Sciences stock falls after announcing IL-6 asset spinout - Investing.com Nigeria
Tiziana Life Sciences plans spinout of IL-6 antibody program - Proactive financial news
Tiziana Life Sciences (TLSA) Plans Spinout to Develop Anti-IL-6 Antibody - GuruFocus
Tiziana Life Sciences Plans to Spin Off IL-6 Antibody Asset Into New Publicly Listed Company - marketscreener.com
Tiziana Life Sciences Plans to Spin Out Asset as Separate Company - marketscreener.com
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company - The Manila Times
Tiziana Life Sciences (Nasdaq: TLSA) to spin out IL-6 asset into new listed company - Stock Titan
Tiziana Life Sciences Ltd (TLSA) -5.03% in After-hours: What’s Driving the Move? - Stocks Telegraph
Take Profit: Why Tiziana Life Sciences Ltd stock appeals to dividend seekersQuarterly Profit Summary & AI Based Trade Execution Alerts - moha.gov.vn
Ready to Jump After Recent Trade: Tiziana Life Sciences Ltd (TLSA) - Setenews
Tiziana Life Sciences Ltd (TLSA) -5.3% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Small cap wrap: Tiziana Life Sciences, Pinnacle Silver & Gold, Rainbow Rare Earths... - Proactive Investors
Phase 2 Trial of Tiziana Life Sciences' Foralumab Gains MyMatch Program Inclusion - GuruFocus
Tiziana Life Sciences’ Phase 2 foralumab trial joins Healey ALS MyMatch Program - Proactive financial news
Tiziana Life Sciences' Foralumab Phase 2 Trial for ALS Accepted into ALS MyMatch Program at Mass General Brigham - Quiver Quantitative
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program - The Manila Times
TLSA ALS Phase 2 intranasal foralumab trial in ALS MyMatch - Stock Titan
Tiziana (Nasdaq: TLSA) Phase 2 nasal foralumab ALS trial joins Healey ALS MyMatch - Stock Titan
Will Tiziana Life Sciences Ltd stock benefit from sector rotation - newser.com
Will Tiziana Life Sciences Ltd stock reach all time highs in 20252025 Performance Recap & AI Driven Stock Reports - newser.com
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.5% – Here’s Why - Defense World
Will Tiziana Life Sciences Ltd stock outperform Nasdaq indexDollar Strength & Daily Profit Focused Screening - newser.com
3 Promising Penny Stocks With At Least $40M Market Cap - Yahoo Finance
Reversal indicators forming on Tiziana Life Sciences Ltd stockAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Applying chart zones and confluence areas to Tiziana Life Sciences Ltd - newser.com
Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):